Abstract
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) has attracted considerable attention as a potential target for the treatment of diabetes and metabolic syndrome. Herein we report the design, synthesis and efficacy evaluation of novel amide and urea 11β-HSD1 inhibitors. Structure-activity relationship studies led to the identification of 10c, which was efficacious in a diabetic ob/ob mouse model and reduced fasting and non-fasting blood glucose levels after ip dosing.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors*
-
Animals
-
Diabetes Mellitus, Type 2
-
Enzyme Activation / drug effects
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Inhibitory Concentration 50
-
Mice
-
Mice, Obese
-
Molecular Structure
-
Piperidines / chemical synthesis*
-
Piperidines / chemistry
-
Piperidines / pharmacology*
-
Structure-Activity Relationship
-
Urea / chemical synthesis*
-
Urea / chemistry
-
Urea / pharmacology
Substances
-
Enzyme Inhibitors
-
Piperidines
-
Urea
-
11-beta-Hydroxysteroid Dehydrogenase Type 1